Curis, Inc. To Present At The Leerink Swann and Company Global Healthcare Conference

Published: Feb 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass., Feb. 5, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today announced that the Company will present at the Leerink Global Healthcare Conference at 10:40 a.m. ET on February 12, 2014, in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news